Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen Johnson

Showing results (31-40 of 101) with videos related to

Pageof 11
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2013
Evaluation of Ara h2 IgE thresholds in the diagnosis of peanut allergy in a clinical populationCorinne A Keet, Kristen Johnson, Jessica H Savage, et al.
American Journal of Clinical Pathology|July 25, 2019
Harmonization of Training, Training Requirements, Board Certification, and Practice of HematopathologySteven H Swerdlow, Sara A Monaghan, Aaron R Douglas, et al.
Experimental Cell Research|May 26, 2005
Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixinPetri Bono, Etchell Cordero, Kristen Johnson, et al.
Journal of Medical Internet Research|November 1, 2018
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods StudyKristina F Simacek, John J Ko, Debbie Moreton, et al.
American Journal of Physiology. Cell Physiology|April 13, 2004
Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1Sucheta M Vaingankar, Thomas A Fitzpatrick, Kristen Johnson, et al.
Current Medical Research and Opinion|September 1, 2017
Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetateMitzi J Williams, Kristen Johnson, Helen M Trenz, et al.
Journal of the Neurological Sciences|February 8, 2019
Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysisEdward Fox, Maria Cecilia Vieira, Kristen Johnson, et al.
Archives of Physical Medicine and Rehabilitation|December 5, 2020
Effect of Different Forms of Activity-Based Recovery Training on Bladder, Bowel, and Sexual Function After Spinal Cord InjuryCharles H Hubscher, Jennifer Wyles, Anthony Gallahar, et al.
Molecular Biology of the Cell|October 20, 2006
Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsShalini Mitra, Lakshmanan Annamalai, Souvik Chakraborty, et al.
Current Medical Research and Opinion|February 4, 2021
Health care resource utilization and disease modifying treatment use in multiple sclerosis patients by age and insurance typeMiriam Cisternas, Lauren Bartolome, Bret Gitar, et al.
Pageof 11

Showing results (31-40 of 101) with videos related to

Sort By:
Pageof 11
The Journal of Allergy and Clinical Immunology. in Practice|November 16, 2013
Evaluation of Ara h2 IgE thresholds in the diagnosis of peanut allergy in a clinical populationCorinne A Keet, Kristen Johnson, Jessica H Savage, et al.
American Journal of Clinical Pathology|July 25, 2019
Harmonization of Training, Training Requirements, Board Certification, and Practice of HematopathologySteven H Swerdlow, Sara A Monaghan, Aaron R Douglas, et al.
Experimental Cell Research|May 26, 2005
Layilin, a cell surface hyaluronan receptor, interacts with merlin and radixinPetri Bono, Etchell Cordero, Kristen Johnson, et al.
Journal of Medical Internet Research|November 1, 2018
The Impact of Disease-Modifying Therapy Access Barriers on People With Multiple Sclerosis: Mixed-Methods StudyKristina F Simacek, John J Ko, Debbie Moreton, et al.
American Journal of Physiology. Cell Physiology|April 13, 2004
Subcellular targeting and function of osteoblast nucleotide pyrophosphatase phosphodiesterase 1Sucheta M Vaingankar, Thomas A Fitzpatrick, Kristen Johnson, et al.
Current Medical Research and Opinion|September 1, 2017
Adherence, persistence, and discontinuation among Hispanic and African American patients with multiple sclerosis treated with fingolimod or glatiramer acetateMitzi J Williams, Kristen Johnson, Helen M Trenz, et al.
Journal of the Neurological Sciences|February 8, 2019
Real-world durability of relapse rate reduction in patients with multiple sclerosis receiving fingolimod for up to 3 years: a retrospective US claims database analysisEdward Fox, Maria Cecilia Vieira, Kristen Johnson, et al.
Archives of Physical Medicine and Rehabilitation|December 5, 2020
Effect of Different Forms of Activity-Based Recovery Training on Bladder, Bowel, and Sexual Function After Spinal Cord InjuryCharles H Hubscher, Jennifer Wyles, Anthony Gallahar, et al.
Molecular Biology of the Cell|October 20, 2006
Androgen-regulated formation and degradation of gap junctions in androgen-responsive human prostate cancer cellsShalini Mitra, Lakshmanan Annamalai, Souvik Chakraborty, et al.
Current Medical Research and Opinion|February 4, 2021
Health care resource utilization and disease modifying treatment use in multiple sclerosis patients by age and insurance typeMiriam Cisternas, Lauren Bartolome, Bret Gitar, et al.
Pageof 11